Literature DB >> 12942886

Recurrent abdominal pain in children: forerunner to adult irritable bowel syndrome?

Monica Jarrett1, Margaret Heitkemper, Danita I Czyzewski, Robert Shulman.   

Abstract

ISSUES AND
PURPOSE: Review the etiology and pathophysiology of recurrent abdominal pain (RAP) and its potential role as a precursor to irritable bowel syndrome (IBS) in adults.
CONCLUSIONS: Physiological mechanisms not easily identifiable as an organic cause may underlie symptoms in RAP patients. They may be triggered by psychosocial factors that result in greater functional disability, more clinic visits, and lower academic and social competence. Of these children, 25% will experience similar symptoms as adults; many will be diagnosed with IBS. PRACTICE IMPLICATIONS: Nurses can provide early and efficient management of these children's care if they view the issues of abdominal pain/discomfort from a broader focus that includes the context of the child's experiences.

Entities:  

Mesh:

Year:  2003        PMID: 12942886     DOI: 10.1111/j.1088-145x.2003.00081.x

Source DB:  PubMed          Journal:  J Spec Pediatr Nurs        ISSN: 1539-0136            Impact factor:   1.260


  13 in total

1.  Recurrent Abdominal Pain in Primary and Tertiary Care: Differences and Similarities.

Authors:  Danita I Czyzewski; Michelle N Eakin; Mariella M Lane; Monica Jarrett; Robert J Shulman
Journal:  Child Health Care       Date:  2007-05-02

2.  Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.

Authors:  Delphine M Saulnier; Kevin Riehle; Toni-Ann Mistretta; Maria-Alejandra Diaz; Debasmita Mandal; Sabeen Raza; Erica M Weidler; Xiang Qin; Cristian Coarfa; Aleksandar Milosavljevic; Joseph F Petrosino; Sarah Highlander; Richard Gibbs; Susan V Lynch; Robert J Shulman; James Versalovic
Journal:  Gastroenterology       Date:  2011-07-08       Impact factor: 22.682

3.  Autonomic nervous system function in young children with functional abdominal pain or irritable bowel syndrome.

Authors:  Monica Jarrett; Margaret Heitkemper; Danita Czyzewski; Lonnie Zeltzer; Robert J Shulman
Journal:  J Pain       Date:  2012-04-20       Impact factor: 5.820

Review 4.  Functional gastrointestinal disorders: past and present.

Authors:  Rana Fayez Ammoury; Marian Del Rosario Pfefferkorn; Joseph Marino Croffie
Journal:  World J Pediatr       Date:  2009-07-09       Impact factor: 2.764

5.  Child and parent perceived food-induced gastrointestinal symptoms and quality of life in children with functional gastrointestinal disorders.

Authors:  Michelle J Carlson; Carolyn E Moore; Cynthia M Tsai; Robert J Shulman; Bruno P Chumpitazi
Journal:  J Acad Nutr Diet       Date:  2013-12-19       Impact factor: 4.910

6.  Endogenous inhibition of somatic pain is impaired in girls with irritable bowel syndrome compared with healthy girls.

Authors:  Amy E Williams; Margaret Heitkemper; Mariella M Self; Danita I Czyzewski; Robert J Shulman
Journal:  J Pain       Date:  2013-05-17       Impact factor: 5.820

7.  Increased gastrointestinal permeability and gut inflammation in children with functional abdominal pain and irritable bowel syndrome.

Authors:  Robert J Shulman; Michelle N Eakin; Danita I Czyzewski; Monica Jarrett; Ching-Nan Ou
Journal:  J Pediatr       Date:  2008-06-09       Impact factor: 4.406

8.  Maintenance of Pain in Children With Functional Abdominal Pain.

Authors:  Danita I Czyzewski; Mariella M Self; Amy E Williams; Erica M Weidler; Allison M Blatz; Robert J Shulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2016-03       Impact factor: 2.839

Review 9.  Dietary issues in recurrent abdominal pain.

Authors:  Robert J Shulman
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-11       Impact factor: 2.839

10.  Evidence of increased fecal granins in children with irritable bowel syndrome and correlates with symptoms.

Authors:  Robert J Shulman; Lena Öhman; Mats Stridsberg; Kevin Cain; Magnus Simrén; Margaret Heitkemper
Journal:  Neurogastroenterol Motil       Date:  2018-10-09       Impact factor: 3.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.